Results 51 to 60 of about 24,772 (224)

Thyrotoxicosis in a 13‐year‐old girl following pituitary adenectomy for Cushing′s disease

Clinical Case Reports, 2017
Key Clinical Message Our objective is to report a case of thyrotoxicosis following pituitary adenectomy for Cushing′s disease, the only pediatric case to our knowledge.
Arndis Audur Sigmarsdottir, Ingvar Hakon Olafsson, Ólafur Kjartansson, Ragnar Bjarnason   +3 more
doaj   +1 more source

Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 1, January 2026.
ABSTRACT Timely diagnosis of type 1 diabetes (T1D), especially in high‐risk populations, is crucial for preventing serious health complications. T1D is a chronic progressive autoimmune disease that has presymptomatic stages that can be identified through the detection of islet autoantibodies. Given that T1D is associated with other autoimmune diseases,
Nick Thomas, Bijay Vaidya, Richard David Leslie, Daniel Agardh, Richard Oram, Dana Dabelea, Arunjot Singh, Dimitrios Chantzichristos, Marian Rewers   +8 more
wiley   +1 more source

Thyroid Cancer Risk in Patients With Type 2 Diabetes Taking Glucagon‐Like Peptide 1 Receptor Agonists

OTO Open, Volume 10, Issue 1, January-March 2026.
Abstract Objective Glucagon‐like peptide 1 receptor agonists (GLP‐1RA) have shown remarkable results in glycemic control for patients with type 2 diabetes (T2DM). While no association has been made, there is a concern for thyroid cancer (TC) from GLP‐1RA. We aimed to study the 5‐year risk of TC in T2DM patients taking GLP‐1RA.
Bao Y. Sciscent, Hanel W. Eberly, F. Jeffrey Lorenz, David Goldrich, Neerav Goyal, David Goldenberg   +5 more
wiley   +1 more source

Thyrotoxicosis. Clinical guidelines for diagnosis and treatment. Part ІІ

Український радіологічний та онкологічний журнал, 2020
Background. Recently they have reported an increased rate of thyrotoxicosis, which is characterized by polyetiology, a variety of clinical manifestations and potential treatment.
Н. С. Підченко, Л. Я. Васильєв, Г. В. Грушка, О. М. Астап’єва, А. С. Cавченко   +4 more
doaj   +1 more source

Identification of Six Potential Therapeutic Targets Common to Ischemic Stroke and Vascular Dementia: Genetic Insights From an Integrated Bioinformatics Analysis

Brain and Behavior, Volume 15, Issue 12, December 2025.
This graphical abstract summarizes a multi‐layered analytical framework integrating cis‐eQTLs, UKB‐PPP proteomics, and multivariable Mendelian randomization to dissect the causal links between circulating proteins, vascular risk factors, ischemic stroke (IS), and vascular dementia (VD).
Jian Lyu, Fa Lin, Yi Liu, Yan Chai, Xiaolin Chen, Min Wang, Fumei Liu, Haiyan Xiao, Guibo Sun, Yanming Xie   +9 more
wiley   +1 more source

Association Between Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Arrhythmias

Journal of Arrhythmia, Volume 41, Issue 6, December 2025.
This study suggests that GLP‐1 RAs use among obese patients was associated with a lower risk of arrhythmias at both 1‐year and 3‐year follow‐ups. ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs), initially designed to treat diabetes mellitus (DM), have demonstrated the potential to mitigate obesity‐related cardiovascular risks.
Vikash Jaiswal, Muhammad Hanif, Aman Goyal, Juveriya Yasmeen, Vamsi Garimella, Yusra Mashkoor, Roopeessh Vempati, Novonil Deb, Yusra Minahil Nasir, Kripa Rajak, Abhigan Babu Shrestha, Jishanth Mattumpuram, Andrew Weinberg   +12 more
wiley   +1 more source

Recurrent Thyrotoxicosis due to Both Graves’ Disease and Hashimoto’s Thyroiditis in the Same Three Patients

Case Reports in Endocrinology, 2016
Hashimoto’s thyroiditis (HT) and Graves’ disease (GD) are the 2 most common autoimmune disease processes affecting the thyroid gland. The relationship between the two is complex and not clearly understood.
Ashley Schaffer, Vidya Puthenpura, Ian Marshall   +2 more
doaj   +1 more source

Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.

Клиническая и экспериментальная тиреоидология, 2017
Thyrotoxicosis has multiple etiologies, manifestations, and potential therapies. Appropriate treatment requires an accurate diagnosis and is influenced by coexisting medical conditions and patient preference.
Valentin V. Fadeyev
doaj   +1 more source

The Evolving Landscape of Immunotoxicity: Charting Mechanisms and Future Strategies for Immune Checkpoint Inhibitor Adverse Events

Med Research, Volume 1, Issue 3, Page 322-358, December 2025.
ABSTRACT The use of immune checkpoint inhibitors (ICIs) has significantly improved the efficacy of cancer therapy, but their associated immune‐related adverse events (irAEs) can severely compromise treatment safety. This review systematically summarizes the core mechanisms underlying irAEs, which include multi‐organ damage resulting from T‐cell ...
Anqi Lin, Keyin Zheng, Aimin Jiang, Xufeng Huang, Qi Wang, András Hajdu, Zhengrui Li, Jian Zhang, Peng Luo   +8 more
wiley   +1 more source

ADRENERGIC REGULATION OF IMMUNE RESPONSE UNDER EXPERIMENTAL THYROTOXICOSIS IN RATS

Acta Biomedica Scientifica, 2012
It was established that a changes of antibody production and reaction of delayed—type hypersensitivity at the local immune response to thymus-dependent antigen were opposite in rats with varying severity of experimental thyrotoxicosis — stimulation under
Ju. I. Shilov, A. P. Godovalov
doaj